Joint Letter of Support for the MEDS Act
Dear Senator Collins and Senator Smith,
The undersigned organizations are writing in support of S.2723 – The Mitigating Emergency Drug Shortages (MEDS) Act. Drug shortages have been on the rise for several years, with an estimated 210 drugs currently at risk or not readily available for U.S. hospitals, according to the national database maintained by the American Society of Health System Pharmacists (ASHP). The Food and Drug Administration (FDA) also states that drug shortages have grown more persistent since 2014 with many shortages lasting multiple years.
Click here to read the full letter.
Related Posts
Comments of the Healthcare Supply Chain Association (HSCA) on FDA Request for Comments on Ensuring a Competitive Marketplace for Biosimilars
On behalf of the Healthcare Supply Chain Association (HSCA), we...
HSCA Names Leading National Healthcare Expert Khatereh Calleja as President & CEO
Washington, DC (April 2, 2019) – The Healthcare Supply Chain Association (HSCA)...
Joint Letter of Support for the MEDS Act
Dear Senator Collins and Senator Smith, The undersigned organizations are...
HSCA Submits Comments to FDA on Using Unique Device Identifiers in Medical Device Safety Communications to Support Accuracy, Quality, and Patient Safety
Washington, DC (January 19, 2021) – The Healthcare Supply Chain Association...